We are live on
!
Find out more
HCM
Highbridge Capital Management Portfolio holdings
AUM
$3.09B
1-Year Est. Return
31.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+31.19%
3 Year Est. Return
+54.53%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.39%
AUM
$8.22B
AUM Growth
+$272M
(+3.4%)
Cap. Flow
-$981M
Cap. Flow
% of AUM
-11.94%
Top 10 Holdings %
Top 10 Hldgs %
21.98%
Holding
1,489
New
477
Increased
218
Reduced
244
Closed
468
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$57.9M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$52.4M |
| 3 |
ExxonMobil
XOM
|
+$49M |
| 4 |
Colgate-Palmolive
CL
|
+$45.4M |
| 5 |
CF Industries
CF
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$64.1M |
| 2 |
Meta Platforms (Facebook)
META
|
+$58.9M |
| 3 |
MON
Monsanto Co
MON
|
+$54.7M |
| 4 |
CELG
Celgene Corp
CELG
|
+$53.6M |
| 5 |
Target
TGT
|
+$52.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 9.92% |
| 2 | Healthcare | 9.35% |
| 3 | Technology | 6.84% |
| 4 | Consumer Discretionary | 5.39% |
| 5 | Industrials | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
VeriSign
VRSN
$26.2B
| $1.09M | 0.01% |
+22,295
| New | +$1.11M |
|
477
Lockheed Martin
LMT
$134B
| $1.07M | 0.01% |
6,688
+4,640
| +227% | +$754K |
|
478
CALL
Starbucks
SBUX
$120B
| $1.07M | 0.01% |
27,800
-7,200
| -21% | -$262K |
|
|
MRD
479
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $1.06M | 0.01% |
+43,718
| New | +$1.05M |
|
480
Future Fuel
FF
$217M
| $1.06M | 0.01% |
+64,152
| New | +$1.17M |
|
481
Hasbro
HAS
$13.2B
| $1.06M | 0.01% |
+20,022
| New | +$1.08M |
|
482
Rogers Corp
ROG
$2.21B
| $1.06M | 0.01% |
+15,985
| New | +$988K |
|
483
BioCryst Pharmaceuticals
BCRX
$2.28B
| $1.05M | 0.01% |
+82,546
| New | +$803K |
|
484
AbbVie
ABBV
$443B
| $1.05M | 0.01% |
18,600
+12,018
| +183% | +$630K |
|
485
BOK Financial
BOKF
$8.58B
| $1.05M | 0.01% |
15,753
-14,461
| -48% | -$946K |
|
486
RingCentral
RNG
$4.66B
| $1.05M | 0.01% |
+69,256
| New | +$1M |
|
487
CALL
3D Systems Corp
DDD
$431M
| $1.05M | 0.01% |
17,500
+4,100
| +31% | +$210K |
|
|
CLVS
488
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.05M | 0.01% |
+25,300
| New | +$1.3M |
|
|
489
Meta Platforms (Facebook)
META
$1.42T
| $1.05M | 0.01% |
15,543
-956,805
| -98% | -$58.9M |
|
|
JCP
490
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.05M | 0.01% |
+115,669
| New | +$997K |
|
491
Reinsurance Group of America
RGA
$15.5B
| $1.04M | 0.01% |
+13,155
| New | +$1.03M |
|
|
AFSI
492
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $1.04M | 0.01% |
+49,598
| New | +$1.02M |
|
493
Jacobs Solutions
J
$15.9B
| $1.03M | 0.01% |
+23,375
| New | +$1.11M |
|
494
PUT
Assured Guaranty
AGO
$3.66B
| $1.02M | 0.01% |
+41,500
| New | +$1.03M |
|
495
SLM Corp
SLM
$4.89B
| $1.01M | 0.01% |
+121,648
| New | +$1.07M |
|
|
N
496
CALL
DELISTED
Netsuite Inc
N
| $1.01M | 0.01% |
+11,600
| New | +$936K |
|
497
Mohawk Industries
MHK
$7.5B
| $1M | 0.01% |
+7,250
| New | +$980K |
|
|
SGYP
498
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $997K | 0.01% |
+244,884
| New | +$1.04M |
|
499
CALL
Medtronic
MDT
$109B
| $989K | 0.01% |
15,500
-7,900
| -34% | -$480K |
|
500
CALL
Standard BioTools
LAB
$340M
| $988K | 0.01% |
+33,600
| New | +$1.08M |
|
Similar funds
DCM
CAM
VBA
MRCP
ECP
TCG
PC
CCI
Highbridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Highbridge Capital Management held 1,489 positions worth $8.22B, up 3.4% from $7.94B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Highbridge Capital Management withdrew a net $981M in Q2 2014, closing 468 positions and reducing 244 holdings. Its most notable exit was Celgene Corp, an estimated $53.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 9.9% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Highbridge Capital Management opened a new position in Bausch Health worth $38.6M.
- Highbridge Capital Management's largest Q2 2014 buy was Bausch Health: 305,899 shares worth $38.6M.
- Highbridge Capital Management added most to Citigroup in Q2 2014, an estimated $57.9M increase.
- Highbridge Capital Management's biggest Q2 2014 reduction was Intel, cutting an estimated $64.1M.
- Highbridge Capital Management fully exited Celgene Corp in Q2 2014, selling an estimated $53.6M.
- Highbridge Capital Management's ten largest holdings make up 22% of its $8.22B portfolio in Q2 2014.
- Highbridge Capital Management opened 477 new positions and closed 468 in Q2 2014.
- Highbridge Capital Management's portfolio value rose 3.4% quarter-over-quarter to $8.22B.
Based on Highbridge Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.